RESMED INC — Director's Dealing 2019

Jul 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-07-01

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-01	ResMed Common Stock	S	3000	$123.17	Disposed	76514	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.